Abiopharma

Publication relating to transparency notifications

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Halliburton First Quarter 2026 Earnings Conference Call

Securities Fraud Investigation Into Super Micro Computer, Inc. (SMCI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

BYND Deadline: Rosen Law Firm Urges Beyond Meat, Inc. (NASDAQ: BYND) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm Urges Concorde International Group Ltd. (NASDAQ: CIGL) Stockholders to Contact the Firm for Information About Their Rights

Faraday Future Confirms Receipt of Minimum Bid Deficiency Notice and 180-Day Extension from Nasdaq to Meet The $1 Per Share Minimum Bid Price Requirement

Securities Fraud Investigation Into Alibaba Group Holding Ltd. (BABA) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, A Leading Securities Fraud Law Firm

Pentair Announces Retirement of Chairman of the Board David A. Jones and Appointment of T. Michael Glenn

Bristol Myers Squibb - Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals forOpdivo® (nivolumab)